1 day agofrench drugmaker sanofi ousted ceo paul hudson on thursday, ending a six-year tenure marked by a stalled drive to replace blockbuster drugs going off patent and rising pressure from u.s.. 1 day agosanofi has replaced its ceo paul hudson after a series of r&d setbacks at the french pharma, handing the reins to merck kgaa leader belén garijo. Following the departure of gsk ceo.
1 day agosanofi has replaced chief executive paul hudson with the head of german drugmaker merck kgaa, after the french drugmaker struggled to develop new treatments under his leadership. 22 hours agohudson is expected to leave his post at the end of the day on feb. 17 hours agooutgoing merck kgaa ceo belén garijo is set take the helm at sanofi, after the french vaccine specialist announced it would not renew existing ceo paul hudson’s contract.
Feb 12, 2006belén garijo to become chief executive officer of sanofi paris, february 12, 2026. Sanofi's board of directors met on february 11, 2026, and decided not to renew the director. 1 day agofrench drugmaker sanofi has replaced ceo paul hudson with belen garijo following underwhelming vaccine sales and investor pressure for a stronger growth strategy.
1 day agosanofi, looking for more ‘rigor,’ swaps ceo hudson for ex-merck kgaa chief garijo the move drew skepticism from investors despite multiple recent research setbacks that have left. 23 hours agoby alessandro parodi and bhanvi satija london — french drugmaker sanofi abruptly ousted its ceo paul hudson on thursday, underscoring rising pressure from headwinds in the us. 1 day agosanofi abruptly replaced chief executive officer paul hudson after a massive research spending boost failed to deliver rapid results, appointing its first female leader, merck kgaa’s belén.